ArticleJournal of clinical immunology2025

Successful Treatment of Skin Dyskeratosis Due To NLRP1 Mutation Using Baricitinib.

Gokce Vatansever et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.